Cargando…
Skeletal muscle loss during neoadjuvant chemotherapy predicts poor prognosis in patients with breast cancer
BACKGROUND: The skeletal muscle index (SMI), which is calculated as the ratio of skeletal muscle area at the third lumbar vertebral level divided by height squared, has been considered a prognostic factor in patients with breast cancer. However, the prognostic impact of changes in SMI during treatme...
Autores principales: | Amitani, Masatsugu, Oba, Takaaki, Kiyosawa, Nami, Morikawa, Hiroki, Chino, Tatsunori, Soma, Ai, Shimizu, Tadafumi, Ohno, Koichi, Ono, Mayu, Ito, Tokiko, Kanai, Toshiharu, Maeno, Kazuma, Ito, Ken-ichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962250/ https://www.ncbi.nlm.nih.gov/pubmed/35346102 http://dx.doi.org/10.1186/s12885-022-09443-1 |
Ejemplares similares
-
Development of a predictive score for post-hemithyroidectomy hypothyroidism using skeletal muscle index, remnant thyroid index, and thyroid-stimulating hormone levels: a retrospective cohort study
por: Amitani, Masatsugu, et al.
Publicado: (2023) -
Fibroadenoma in a young male breast: A case report and review of the literature
por: Morikawa, Hiroki, et al.
Publicado: (2021) -
Papillary thyroid microcarcinoma with lung metastases: a case report and review of the literature
por: Shimizu, Tadafumi, et al.
Publicado: (2021) -
Neoadjuvant chemotherapy-induced decrease of prognostic nutrition index predicts poor prognosis in patients with breast cancer
por: Oba, Takaaki, et al.
Publicado: (2020) -
Lipid-rich carcinoma of the breast that is strongly positive for estrogen receptor: a case report and literature review
por: Oba, Takaaki, et al.
Publicado: (2016)